BARNIDIPINE TEVA 20 mg PROLONGED-RELEASE HARD CAPSULES

2. What you need to know before you take Barnidipine Teva

Do not takeBarnidipine Teva

• if you are allergic to barnidipine or any of the other ingredients of this medicine (listed in section 6)
• if you are allergic to dihydropyridines (used for the treatment of high blood pressure)
• if you have liver disease
• if you have severe kidney disease
• if you have these specific heart diseases: untreated heart failure, certain forms of chest pain (unstable angina) or acute heart attack
• if you are taking one of the following medicines: protease inhibitors (medicines used for the treatment of AIDS), ketoconazole or itraconazole (medicines for the treatment of fungal infections), erythromycin or clarithromycin (antibiotics, see "Other medicines and Barnidipine Teva").

Warnings and precautions

Consult your doctor or pharmacist before taking Barnidipine Teva

• if you have kidney disease
• if you have heart disease

Children and adolescents

Barnidipine must not be used in children or adolescents under 18 years.

Other medicines and Barnidipine Teva

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

This is especially important if you are using any of the following medicines as they MUST NOTbe used with barnidipine (see "Do not take Barnidipine Teva"):

• protease inhibitors (medicines used for the treatment of AIDS)
• ketoconazole or itraconazole (medicines for the treatment of fungal infections)
• erythromycin or clarithromycin (antibiotics).

Also, inform your doctor if you are taking:

• Other medicines used for the treatment of high blood pressure, as they may cause additional blood pressure reduction.
• Cimetidine (a medicine used for the treatment of stomach problems) as it may increase the effect of barnidipine.
• Phenytoin or carbamazepine (medicines used for the treatment of epilepsy) or rifampicin (an antibiotic) as higher doses of barnidipine may be needed. If you stop treatment with these medicines, your doctor may decrease the dose of barnidipine.

Taking Barnidipine Tevawith drinks and alcohol

Be particularly careful when drinking alcohol or grapefruit juice, as they may increase the effect of barnidipine.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

You should not use this medicine during pregnancy unless clearly necessary.

You should not use this medicine if you are breast-feeding. Barnidipine may pass into breast milk.

Driving and using machines

There is no information to suggest that this medicine affects the ability to drive or use machines. However, as this medicine may cause dizziness, you should know how it affects you before driving or using machines.

Barnidipine Teva contains sucrose

If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

3. How to take Barnidipine Teva

Take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.

The recommended initial dose is 10 mg once a day. Your doctor may increase this dose to 1 capsule of 20 mg once a day or 2 capsules of 10 mg once a day.

If you are an elderly person, you can take the normal dose. It is likely that your doctor will monitor you closely at the beginning of treatment.

Instructions for use

• Take the capsule once a day, in the morning. It is recommended to associate taking the capsule with something you do every day, such as brushing your teeth or having breakfast.
• Swallow the capsule whole, preferably with a glass of water. You can take this medicine before, during, or after meals, as you prefer.
• Even when you do not feel any signs or symptoms of high blood pressure, it is important that you continue taking this medicine every day to get all the benefits of blood pressure reduction.

If you take more Barnidipine Tevathan you should

If you have accidentally taken a large number of capsules at once, you should immediatelyconsult your doctor or someone should take you to the emergency department. The possible symptoms of overdose include weakness, slowing or increased heart rate, drowsiness, confusion, nausea, vomiting, and convulsions.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Barnidipine Teva

If you forget to take your dose of barnidipine at the usual time, take it as soon as possible on the same day.

If more than 24 hours have passed, DO NOTtake a double dose to make up for the forgotten doses and continue with the usual schedule once a day.

If you have any further questions on the use of this medicine or want to stop treatment, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you experience a severe allergic reaction that causes difficulty breathing or dizziness, you should inform your doctor or nurse immediately.

Barnidipine may cause the following:

Very common: may affect more than 1 in 10 people

• headache
• flushing
• fluid accumulation (edema) in arms and legs

Common: may affect up to 1 in 10 people

• dizziness
• palpitations

Frequency not known: frequency cannot be estimated from the available data

• rapid heartbeats
• blood tests showing changes in liver function
• rash

These side effects tend to decrease or disappear during treatment (within a month for fluid accumulation and within two weeks for flushing, headache, and palpitations).

The following side effects have been observed in some of the other medicines belonging to the same group of medicines as barnidipine:

• gum overgrowth (gingival hyperplasia),
• rarely, chest pain (precordial pain) or chest tightness (angina pectoris) (may affect up to 1 in 1,000 people),
• very rarely, an increase in the frequency or severity of angina attacks in patients with pre-existing angina (may affect up to 1 in 10,000 people)
• heart attack (myocardial infarction) has been observed in isolated cases.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Barnidipine Teva

Keep this medicine out of the sight and reach of children.

Do not store above 25°C.

Do not use this medicine after the expiry date which is stated on the blister and on the carton after EXP. The expiry date refers to the last day of the month shown.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

What Barnidipine Teva contains

• The active substance is barnidipine. Each capsule contains 20 mg of barnidipine hydrochloride, equivalent to 18.6 mg of barnidipine.
• The other ingredients (excipients) are:

Contents of the capsule: sugar spheres (with sugar syrup, corn starch, and sucrose), carboxymethylcellulose, polysorbate 80, ethylcellulose, talc.

Body of the capsule: titanium dioxide (E171), yellow iron oxide (E172), gelatin.

Printing ink: shellac, propylene glycol, black iron oxide (E172), potassium hydroxide.

Appearance ofBarnidipine Tevaand pack contents

Barnidipine Teva 20 mg prolonged-release hard capsules EFG are hard gelatin capsules filled with granules, yellow to yellowish in color. The cap of the capsule is yellow with black printing "1000" and the body is yellow with black printing "0020".

Available in perforated and non-perforated blisters of 28, 30, 56, or 60 capsules.

Not all pack sizes may be marketed.

Marketing authorisation holder and manufacturer

Marketing authorisation holder:

Teva B.V.

Swensweg 5

2031 GA Haarlem

Netherlands

Manufacturer

Teva Nederland BV

Swensweg 5

Haarlem 2031 GA

Netherlands

or

Teva Operations Poland Sp. z.o.o

ul. Mogilska 80

Krakow, 31-546

Poland

or

Balkanpharma-Dupnitsa AD

3 Samokovsko Shosse Str.

Dupnitsa, 2600

Bulgaria

You can request more information about this medicine from the local representative of the marketing authorisation holder:

Teva Pharma, S.L.U

C/ Anabel Segura, 11, Edificio Albatros B, 1ª planta,

Alcobendas 28108, Madrid (Spain)

Date of last revision of this leaflet:February 2022

You can access detailed and updated information about this medicine by scanning the QR code included in the packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/info/87090

Detailed and updated information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/